Most multiple myeloma studies involve people of European descent, but the disease is more likely to affect African-AmericansContinue reading→

Last year, pancreatic cancer overtook breast cancer as the third leading cause of cancer deaths. WIth a five-year survival rate of just 8 percent, it is one of the deadliest forms of cancer.Continue reading→

For 14 years, the Mayo Clinic and ASU seed grant program has been funding – or seeding –new research collaborations between ASU and Mayo Clinic researchers aimed at improving patient care. By launching novel research on a small scale, researchers have been able to attract funding needed for larger studies and are making significant impact in their fields of studyContinue reading→

Continue reading→

TGen supports Arizona Myeloma Network efforts to share knowledge with cancer caregivers, minimizing their stress and improving patient outcomesContinue reading→

Tiny island nation makes big splash in confronting the world’s third leading cause of cancer deathContinue reading→

If you have not been scared enough by Halloween, read this consent decree announcement made by the FDA on November 1 to Philips Healthcare concerning quality control issues with their automatic external defibrillator. Philips had “tricked” industry by consistently providing unsafe defibrillators so the FDA “treated” them to a cease and desist order through a mandate from a federal judge. Under this consent decree, Philips must cease manufacturing until corrective action is taken.Continue reading→

Dr. Fariba Donovan, an infectious diseases research scientist at the University of Arizona College of Medicine – Tucson, receives contract to examine how the failure to diagnose Valley fever impacts patient health, costs and `antimicrobial stewardship’ of this respiratory infection endemic to the U.S. Southwest.Continue reading→

Is It Obesity or Lipedema? UA Researcher Receives Grant To Study Genetic Risk Factors: Yann Klimentidis, PhD, a genetic epidemiologist at the University of Arizona Mel and Enid Zuckerman College of Public Health, has received funding to study the genetic risk factors for developing lipedema, a painful and body disfiguring condition affecting an estimated 11 percent of U.S. adult women.Continue reading→